-
Crain's Detroit Business - Fri Nov 6, 8:08 pm ET
Ann Arbor-based Aastrom Biosciences Inc. (Nasdaq: ASTM) reported progress Friday in a wide variety of human trials for its stem-cell-based products, but continued losses for the first quarter of its fiscal year, which ended Sept. 30.
-
HealthDay via Yahoo! News - Fri Nov 6, 4:04 pm ET
FRIDAY, Nov. 6 (HealthDay News) -- Belgian scientists who used embryonic stem cells to create lung tissue say this technique could provide an alternative to lung transplants for patients with chronic obstructive pulmonary disease (COPD) and cystic fibrosis.
-
KTVN Reno - Fri Nov 6, 9:20 am ET
THURSDAY, Nov. 5 (HealthDay News) -- Adult stem cells from bone marrow can prevent acute lung injury in mice, U.S. researchers report. Acute lung injury, which is caused by major inflammation or injury to the lungs, causes about 74,500 deaths each year in the United States.
-
Science Daily - Fri Nov 6, 12:20 am ET
For the first time, researchers have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
-
redOrbit - Thu Nov 5, 5:19 pm ET
A gene associated with longevity in roundworms and humans has been shown to affect the function of stem cells that generate new neurons in the adult brain, according to researchers at the Stanford University School of Medicine.
-
The Memphis Daily News - Fri Nov 6, 1:05 am ET
Baptist Memorial Health Care-Memphis has begun its first clinical study involving a stem cell treatment for heart attacks.Dr. Frank A. McGrew III at S....
-
redOrbit - Thu Nov 5, 2:18 pm ET
The same genes that are chemically altered during normal cell differentiation, as well as when normal cells become cancer cells, are also changed in stem cells that scientists derive from adult cells, according to new research from Johns Hopkins and Harvard.Although genetically identical to the mature body cells from which they are derived, induced pluripotent stem cells (iPSCs) are notably ...
-
Marketwire - Thu Nov 5, 10:11 am ET
Histostem to Provide Hematopoietic Stem Cells to a Major Hong Kong Hospital for the Treatment of Leukemia
-
Science Daily - Thu Nov 5, 2:15 pm ET
A gene associated with longevity in roundworms and humans has been shown to affect the function of stem cells that generate new neurons in the adult brain, according to researchers. The study in mice suggests that the gene may play an important role in maintaining cognitive function during aging.
-
San Francisco Chronicle - Thu Nov 5, 12:20 pm ET
Stem cell researchers at the Gladstone Institute in San Francisco and Stanford Medical School have joined a new national consortium linking teams of scientists who normally work independently with other groups that seek to discover new therapies for varied...
-
Providence Business News - Thu Nov 5, 2:35 pm ET
PROVIDENCE – Rhode Island Hospital will receive $11 million over five years to develop a major stem-cell research center that will focus on stem-cell biology and tissue-regeneration techniques that could be used to treat marrow and lung diseases.
-
Pasadena Star-News - Wed Nov 4, 9:58 pm ET
DUARTE - California's stem cell research program has awarded City of Hope two multi-million-dollar grants to develop treatments for brain cancer and HIV.
-
PRWeb via Yahoo! News - Thu Nov 5, 2:05 am ET
At this crucial time, when the federal government is not funding any new human embryonic stem cell grants while federal guidelines are being organized, the Bedford Stem Cell Research Foundation's Seventh Annual Activated Egg Symposium is bringing together an elite group of speakers from Connecticut, Massachusetts and California to share their latest research with other scientists, mostly funded ...
-
MedCity News - Fri Nov 6, 10:04 am ET
CLEVELAND, Ohio -- Athersys Inc. continued enrollments during the third quarter in safety and efficacy trials of its adult stem cell therapy, MultiStem, for heart attack patients and those who run the risk of rejecting bone marrow transplants. At the same time, the clinical-stage biopharmaceutical company looked for money for a third trial involving stroke patients. "We believe MultiStem ...
-
BioresearchOnline - Wed Nov 4, 9:27 am ET
The new market research report, 'Global Stem Cell and Advanced Technologies Market' (2009 - 2014)', published by MarketsandMarkets (http://www.marketsandmarkets.com) analyzes the major trends in the global stem cell market.